Skip to main content
Clinical Trials/JPRN-UMIN000053506
JPRN-UMIN000053506
Recruiting
未知

Prospective observational study of COVID-19 patients in the TOKUSHUKAI GROUP - ANCHOR Study

Shionogi & Co., Ltd.0 sites30,000 target enrollmentFebruary 1, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
The purpose of this study is to collect information of the clinical course of patients with COVID-19 treated at Tokushukai hospitals with and without antiviral drugs and to explore the clinical course in the acute phase, the frequency of severe disease, and frequency of post COVID-19 condition by the treatment, after adjusting by patient background including risk factor(s) and symptoms at the time of registration.
Sponsor
Shionogi & Co., Ltd.
Enrollment
30000
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 1, 2024
End Date
December 31, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Shionogi & Co., Ltd.

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who meet at least one of the following criteria are excluded. 1\) Patients who received anti\-SARS\-Cov\-2 drugs within 30 days prior to registration. 2\) Patients who have previously participated in this study. 3\) Patients who are currently participating in a clinical trial or an interventional prospective study. (Excluding minor interventions) 4\) Patients who have not passed 150 days since the last dose of investigational study drug or unapproved drug.

Outcomes

Primary Outcomes

Not specified

Similar Trials